Earnings Bonanza: Exclusive Stock Alert Inside!

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Beyond AI Stocks: The Rare Element Crucial To Modern Tech]( [Read this stunning report on a potential "tech" investment strategy]( --------------------------------------------------------------- February 8, 2024 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [Rare Chance to Be an Early Investor in AI Energy Breakthrough]( expert Ian King has found a way to invest in the technology powering AI energy. A breakthrough that presents a once-in-a-lifetime opportunity for fast-acting investors. [Just go here for full details.]( --------------------------------------------------------------- [Anebulo Pharmaceuticals, Inc.]( Symbol: [ANEB]( Recent Price: $2.57 Average Analyst Price Target: $6.67 (159.40%) Market Cap: $65.88M Last Year's EPS: $-0.1 Consensus EPS Forecast: $-0.11 Expected Earnings Date: Feb 09, 2024 Recent Analyst Action: Michael Okunewitch, analyst at Maxim Group, reiterates coverage on [Anebulo Pharmaceuticals, Inc. (ANEB)]( in the Healthcare sector with a Buy rating and a price target of $6 (2 months ago). [TipRanks.com]( also reports that [Anebulo Pharmaceuticals, Inc.]( currently has 3 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $6.67 . The target pricing ranges from a high forecast of $8 down to a low forecast of $6. [Anebulo Pharmaceuticals, Inc. (ANEB)](’s last closing price was $2.57 which would put the average price target at 159.40% upside. Here are 3rd party ratings for [ANEB](: - TipRanks.com: Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 40% (99 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [This Stock Could Go Up 66% or More.]( Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. [More here.]( --------------------------------------------------------------- [Essent Group Ltd.]( Symbol: [ESNT]( Recent Price: $53.14 Average Analyst Price Target: $57.20 (7.64%) Market Cap: $5.67B Last Year's EPS: $1.61 Consensus EPS Forecast: $1.57 Expected Earnings Date: Feb 09, 2024 Recent Analyst Action: Terry Ma, analyst at Barclays, reiterates coverage on [Essent Group Ltd. (ESNT)]( in the Financial Services sector with a Hold rating and a price target of $63 (4 weeks ago). [TipRanks.com]( also reports that [Essent Group Ltd.]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $57.20 . The target pricing ranges from a high forecast of $63 down to a low forecast of $54. [Essent Group Ltd. (ESNT)](’s last closing price was $53.14 which would put the average price target at 7.64% upside. Here are 3rd party ratings for [ESNT](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Sell, Top 14% (36 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Mr. Cooper Group Inc.]( Symbol: [COOP]( Recent Price: $67.66 Average Analyst Price Target: $80.50 (18.98%) Market Cap: $4.37B Last Year's EPS: $1.66 Consensus EPS Forecast: $1.73 Expected Earnings Date: Feb 09, 2024 Recent Analyst Action: Eric Hagen, analyst at BTIG, reiterates coverage on [Mr. Cooper Group Inc. (COOP)]( in the Financial Services sector with a Hold rating (1 week ago). [TipRanks.com]( also reports that [Mr. Cooper Group Inc.]( currently has 4 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $80.50 . The target pricing ranges from a high forecast of $88 down to a low forecast of $73. [Mr. Cooper Group Inc. (COOP)](’s last closing price was $67.66 which would put the average price target at 18.98% upside. Here are 3rd party ratings for [COOP](: - TipRanks.com: Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Bottom 27% (183 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [URGENT: Don't risk your retirement]( looming recession, inflation, unpayable debt, a failing dollar, and a crumbling housing market all put your savings in extreme risk. Protect your retirement with this free guide that shows you how to guard your money against economic downturns with gold. Take action NOW, before it’s too late, Download your free guide and see for yourself why gold is the #1 safe haven for smart investors. [Protect your retirement with this free gold guide]( --------------------------------------------------------------- [Embecta Corp.]( Symbol: [EMBC]( Recent Price: $17.46 Average Analyst Price Target: $16.50 (-5.50%) Market Cap: $1.00B Last Year's EPS: $0.59 Consensus EPS Forecast: $0.45 Expected Earnings Date: Feb 09, 2024 Recent Analyst Action: Kallum Titchmarsh, analyst at Morgan Stanley, reiterates coverage on [Embecta Corp. (EMBC)]( in the Healthcare sector with a Sell rating and a price target of $16 (2 months ago). [TipRanks.com]( also reports that [Embecta Corp.]( currently has 2 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $16.50 . The target pricing ranges from a high forecast of $17 down to a low forecast of $16. [Embecta Corp. (EMBC)](’s last closing price was $17.46 which would put the average price target at -5.50% upside. Here are 3rd party ratings for [EMBC](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Bottom 32% (169 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [PepsiCo, Inc.]( Symbol: [PEP]( Recent Price: $171.47 Average Analyst Price Target: $185.00 (7.89%) Market Cap: $235.75B Last Year's EPS: $2.25 Consensus EPS Forecast: $1.72 Expected Earnings Date: Feb 09, 2024 Recent Analyst Action: Nik Modi, analyst at RBC Capital, reiterates coverage on [PepsiCo, Inc. (PEP)]( in the Consumer Defensive sector with a Hold rating and a price target of $180 (1 day ago). [TipRanks.com]( also reports that [PepsiCo, Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $185.00 . The target pricing ranges from a high forecast of $210 down to a low forecast of $172. [PepsiCo, Inc. (PEP)](’s last closing price was $171.47 which would put the average price target at 7.89% upside. Here are 3rd party ratings for [PEP](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 22% (54 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [My Gift to You]( I have arranged for you to receive [a complimentary 3-month subscription]( to Bernie Schaeffer’s Option Advisor online newsletter. [CLICK HERE]( for 3 Months FREE of Bernie Schaeffer’s Option Advisor ($395 Retail Value - [FREE!]() --------------------------------------------------------------- [Magna International Inc.]( Symbol: [MGA]( Recent Price: $58.53 Average Analyst Price Target: $65.60 (12.08%) Market Cap: $16.76B Last Year's EPS: $1.5 Consensus EPS Forecast: $1.33 Expected Earnings Date: Feb 09, 2024 Recent Analyst Action: Tamy Chen, analyst at BMO Capital, reiterates coverage on [Magna International Inc. (MGA)]( in the Consumer Cyclical sector with a Buy rating and a price target of $67 (1 week ago). [TipRanks.com]( also reports that [Magna International Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $65.60 . The target pricing ranges from a high forecast of $77 down to a low forecast of $60. [Magna International Inc. (MGA)](’s last closing price was $58.53 which would put the average price target at 12.08% upside. Here are 3rd party ratings for [MGA](: - TipRanks.com: Hold - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Sell, Top 44% (110 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [ImmunoGen, Inc.]( Symbol: [IMGN]( Recent Price: $29.55 Average Analyst Price Target: $31.07 (5.13%) Market Cap: $8.25B Last Year's EPS: $-0.02 Consensus EPS Forecast: $0.04462 Expected Earnings Date: Feb 09, 2024 Recent Analyst Action: John Newman, analyst at Canaccord Genuity, reiterates coverage on [ImmunoGen, Inc. (IMGN)]( in the Healthcare sector with a Hold rating and a price target of $31.26 (2 months ago). [TipRanks.com]( also reports that [ImmunoGen, Inc.]( currently has 4 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $31.07 . The target pricing ranges from a high forecast of $31.26 down to a low forecast of $31. [ImmunoGen, Inc. (IMGN)](’s last closing price was $29.55 which would put the average price target at 5.13% upside. Here are 3rd party ratings for [IMGN](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Strong Buy, Top 37% (92 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [This New Tech Could Be Worth THREE TIMES the Entire New York Stock Exchange...]( believe this new tech will create more wealth than all the fortunes of the last 150 years combined. That’s why the world’s richest men and even the United States Senate approved throwing hundreds of BILLIONS of dollars into this new technology… [And right now, there’s a little-known stock at the center of all the action.]( In fact, this small-cap stock is still trading for less than it costs to buy a tank of gas. [Click here now for the whole story.]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketInsidersPress.com MarketInsidersPress.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to MarketInsidersPress.com MarketInsidersPress.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane | Mooresville NC | 28115 MarketInsidersPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mount Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software